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Abstract
Purpose: Advanced ion beam therapeutic techniques, such as hypofractionation, respiratory gat-
ing, or laser-based pulsed beams, have dose rate time structures which are substantially different15
from those found in conventional approaches. The biological impact of the time structure is me-
diated through the β parameter in the linear quadratic (LQ) model. The aim of this study is
to assess the impact of changes in the value of the β parameter on the treatment outcomes, also
accounting for non instantaneous intra-fraction dose delivery or fractionation and comparing the
effects of using different primary ions.20
Methods: An original formulation of the microdosimetric kinetic model (MKM) is used (named
MCt-MKM), in which a Monte Carlo (MC) approach was introduced to account for the stochastic
spatio-temporal correlations characteristic of the irradiation process and the cellular repair kinet-
ics. A modified version of the kinetic equations, validated on experimental cell survival in-vitro
data, was also introduced. The model, trained on the HSG cells, was used to evaluate the relative25
biological effectiveness (RBE) for treatments with acute and protracted fractions. Exemplary cases
of prostate cancer irradiated with different ion beams were evaluated to assess the impact of the
temporal effects.
Results: The LQ parameters for a range of cell lines (V79, HSG and T1) and ion species (H, He,
C and Ne) were evaluated and compared with the experimental data available in the literature,30
with good results. Notably, in contrast to the original MKM formulation, the MCt-MKM explicitly
predicts an ion and LET dependent β compatible with observations. The data from a split-dose
experiment were used to experimentally determine the value of the parameter related to the cellular
repair kinetics. Concerning the clinical case considered, an RBE decrease was observed, depending
on the dose, ion and LET, exceeding up to 3% of the acute value in the case of a protraction in35
the delivery of 10 minutes. The intercomparison between different ions shows that the clinical op-
timality is strongly dependent on a complex interplay between the different physical and biological
quantities considered.
Conclusions: The present study provides a framework for exploiting the temporal effects of dose
delivery. The results show the possibility of optimizing the treatment outcomes accounting for the40
correlation between the specific dose rate time structure and the spatial characteristic of the LET
distribution, depending on the ion type used.
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I. INTRODUCTION
In the last few decades there has been a growing interest toward ion beam therapy due
to its attractive features such as a higher conformal dose distribution if compared to photon45
beams and an increased relative biological effectiveness (RBE) [1, 2]. Nevertheless, the
increased RBE of ions also represents a potential disadvantage because of the experimental
uncertainty associated with this quantity [3, 4] and the difficulties encountered in modeling
it. An incorrect estimation of this parameter could compromise the effectiveness of the whole
treatment or even lead to serious side effects. This quantity is closely related to the cellular50
response and the sensitivity to irradiation, described by the α and β parameters according
to the linear quadratic (LQ) model. In this context, a particular importance is assumed by
the β parameter, which modulates the biological impact of the dose rate time structure. In
fact, according to the LQ formulation, the cell survival can be expressed as:
S = exp(−αD −Gβ D2) (1)55
where G represents the generalized Lea-Catcheside factor [5–7] which only depends on the
dose rate time structure. Hence, an increase in the cell survival with respect to the acute
irradiation is expected when considering protracted or fractionated irradiation, since it gives
G < 1, and this effect only involves the quadratic term of equation 1 which is modulated by
the β parameter.60
A dependence of the value of the β parameter on the linear energy transfer (LET) of the
radiation and the particle used has been observed by several authors, and a global analysis
of all the published in-vitro experimental data until 2012 was carried out by Friedrich et
al. [8] and references therein. This analysis seems to indicate that, irrespective of the cell
or ion types, β shows a general decrease with high values of LET. A similar analysis of the65
the β vs. LET using the same data partitioned in normal and tumor cell was also performed
independently by us with similar results and it is reported in the supplementary material
(figure S1). On the other hand, several authors report an increasing β with increasing LET
[9–12]. However, the behaviour of this parameter as a function of LET is still controversial
because of the experimental uncertainty associated with the available data and the difficul-70
ties characterizing its measurement. Such an uncertainty is also transferred to the modeling,
so that different models predict completely different behaviours of β: exemplary cases are
the local effect model (LEM) [13–18], the microdosimetric-kinetic model (MKM) [19–23]
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and the repair-misrepair fixation (RMF) model [24] which predict a decreasing, a constant
and an increasing β with increasing LET respectively. These models are commonly used in75
treatment planning in many facilities all over the world, in particular the LEM has been
used for many years by clinical centers such as GSI, HIT and CNAO [25–28], the MKM
was recently introduced into the clinical practice by the NIRS [29], while the RMF is only
used for research purposes [30]. Moreover, most of the models neglect the β dependence on
the dose rate time structure and consequently they do not take into account the increase in80
cell survival observed for dose protraction or fractionation. Therefore, nowadays treatment
plans are made on the assumption that the beams are delivered instantaneously regardless
of the real intra-fraction time structure. Nonetheless, the most advanced ion beam thera-
peutic techniques, such as hypofractionation, respiratory gating, repainting or, looking at
the future, laser-based pulsed beams, have dose rate time structures which are substantially85
different from those found in conventional approaches and whose biological impact needs to
be investigated. In this regard, some precursory study have been carried out by Inaniwa et
al. [31, 32], who tried to quantify the dose-delivery protraction effect of the irradiation using
the MKM but neglecting the β dependence on LET and limiting the analysis to carbon
ion beams, and by Carabe-Fernandez et al. [33] who studied the clinical implications of a90
variable β on fractionation and the related variability of the RBE.
The aim of this study is to assess the impact of changes in the value of the β parameter
on the treatment outcomes, also accounting for an arbitrary dose rate time structure and
comparing the effect of using different primary ions. An original formulation of the MKM
(named MCt-MKM) was conceived and implemented to address this issue; in particular, it95
was included in a treatment planning system (TPS) and used to evaluate the effect of non
instantaneous intra-fraction dose-delivery in a clinical case of prostate cancer. We remark
that in this clinical study, the only time-dependent radiobiological mechanisms explicitly
modelled are those associated to the repair kinetics of the cell, while other mechanism such
as oxygen effect, tumoral cell repopulation and cell cycle are not accounted for.100
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II. MATERIALS AND METHODS
A. The Monte Carlo temporal-Microdosimetric Kinetic Model
At present, one of the most acknowledged radiobiological models is the microdosimetric-
kinetic model (MKM), formulated by Hawkins in 1994 [19] as an elaboration of the theory
of dual radiation action (TDRA) [34, 35], the repair-misrepair [36] and the lethal-potentially105
lethal models [37] and then modified over subsequent years [20–23]. Here, an original refor-
mulation of this model is presented, based on a Monte Carlo approach and named Monte
Carlo temporal-Microdosimetric Kinetic Model (MCt-MKM), that also includes the ana-
lytic solution of the kinetic equations formulated by Hawkins and allows to evaluate the
temporal effects of the irradiation. The aim of the model is to predict the surviving fraction110
of cells exposed to ionizing radiation with a completely arbitrary dose rate time structure,
where the term “dose rate time structure”, is used to indicate the temporal pattern of the
dose rate, the latter intended as a function of time in the most general sense; within this
definition we consider both the modulations of the dose rate as a function of time due to
the fractionation (inter-fraction time), and due to the specific intra-fraction dose delivery,115
such as single fraction protraction. According to the model hypothesis, the cell survival
probability corresponds to the probability that the number of lethal lesions in the cellular
nucleus results equal to zero after a large period of time after the irradiation, that is in the
limit of the time that increases to infinite. The nucleus is divided into subcellular structures,
named domains, similar to the sites defined in the TDRA and the model is based on the120
hypothesis that ionizing radiation can cause two kinds of primary lesions in the domain,
referred to as type I (x
(cd)
I ) and II (x
(cd)
II ) lesions. The rate of production of type I (x˙
(cd)
I ) and
II (x˙
(cd)
II ) lesions is proportional to the dose rate (z˙
(cd)), with proportionality constant λ and
k respectively; the superscript c and d refer to the specific cell and domain considered. Type
I lesions are associated with clustered DNA damages which are directly lethal for the cell,125
while type II lesions identify non-directly lethal damages that may be repaired with constant
rate r, spontaneously converted to irreparable damages with a first-order constant rate a
or undergo pairwise combination with other type II lesions in a second-order process with
constant rate b. These assumptions led to the formulation of the following kinetic equations
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that describe the evolution of the number of type I and II lesions inside each domain:130 x˙
(cd)
I = λ z˙
(cd) + ax
(cd)
II + b (x
(cd)
II )
2
x˙
(cd)
II = k z˙
(cd) − (a+ r)x(cd)II − 2b (x(cd)II )2
(2)
where z˙(cd) indicates the microscopical dose absorbed by the d -th domain of the c-th cell
per unit of time. However, in the case of ion irradiation, the rate of pairwise combination
between type II lesions is considered negligible in the evaluation of x˙
(cd)
II [20, 31, 32] if
compared to the first order process (i.e. 2b (xcdII)
2 << (a+ r)x
(cd)
II ), hence the quadratic term135
will be neglected in the calculations. As a consequence, equation 2 becomes:x˙
(cd)
I = λ z˙
(cd) + ax
(cd)
II + b (x
(cd)
II )
2
x˙
(cd)
II ' k z˙(cd) − (a+ r)x(cd)II
(3)
Since the distribution of type I lesions in the nucleus is assumed to be Poissonian, the
surviving probability for the c-th cell in the irradiated population can be calculated as
Sc = exp
(
−
ND∑
d=1
lim
t→+∞
x
(cd)
I (t)
)
= exp
(
−
ND∑
d=1
x˜
(cd)
I
)
(4)140
where ND indicates the total number of domains constituting the cell nucleus. Once defined
the dose rate time structure, the quantity x˜
(cd)
I is evaluated by solving the kinetic equations
(3).
In the MC computational procedure the choice of cell nucleus and domain geometries are
those used by Kase et al. [23]. The sensitive volumes of domain and nucleus is cylindrical,145
the paths of incident ions are parallel to the cylindrical axis and a track segment condition is
assumed for the sake of simplifying the calculations. The domains were arranged according to
a close packing hexagonal structure inside the nucleus (figure S4, supplementary materials)
that is assumed to be water equivalent. The number of domains follows simply from the
ratio between the nucleus and domain areas. The sizes of the nucleus and of the domains,150
reported in table I, have been derived by fitting the experimental data. They are compatible
with the ones used in other studies (such as [23]). The corresponding number of domains
per nucleus used in the simulations is in the range 106–166 depending on the cell type.
From the point of view of the single domain, the macroscopic irradiation process could be
seen as an ordered sequence of interactions between the ions composing the beam and domain155
itself, where the number of ions, the time of each interaction and the impact parameter of
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each ion can be sampled from specific probability distributions depending on the dose rate
time structure and the kind of irradiation considered. In the most general case of mixed field
irradiation, the interacting beam is made of primary ions and fragments with a spectrum
of energies. This spectrum is an input for the model and could be evaluated by means of160
other simulation codes. In particular, we used a monoenergetic spectrum in the comparison
with the in-vitro data (see section III A), while, in the case of the treatment plan, we used a
complex spectrum (including fragments) derived from the TPS calculations, which in turn
is based on FLUKA calculations (see section II B and III C) For each energy and particle
type, once defined the imposed macroscopic dose D, the mean number of ions interacting165
with the nucleus is obtained as:
N¯e =
ρ σ Dwe
〈LET〉 (5)
where σ indicates the cross section, ρ the density of the tissue, the index e refers to the
histogram bin of the energy spectrum for each particle type, we is the normalized weight of
the e-th energy and particle type component of the spectrum, and 〈LET〉 the mean LET170
of the radiation. Hence, the actual number of interacting ions is sampled from a Poissonian
probability density function (PDF) with mean value N¯e.
For the evaluation of the single i -th particle contribution to the specific energy per cell
and domain, z
(cd)
i , the MCt-MKM integrates in the domain region the analytical formula for
the amorphous track model obtained by a combination of the Kiefer model for the penumbra175
region [38] and the Chatterjee model for the core radius [39], following the approach of Kase
et al. [23]. The spatial coordinates of each particle with respect to the center of the cell are
sampled from a uniform PDF.
In the MC simulation the time is implemented by defining, during the initialization
phase, a macroscopic time structure for the dose rate to be delivered. At the beginning180
of the simulation of each cell c, a number of particles is extracted (see equation 5) and,
together with the spatial coordinate, a randomly generated temporal coordinate, t
(c)
i , is also
assigned to each one of them. The temporal coordinate is sampled from a temporal PDF
that is proportional to the macroscopic dose rate time-function and it is used as an input of
the model. The particles are then time-ordered to define a temporal sequence with ordered185
time indices, so that if i > j then t
(c)
i ≥ t(c)j . The interaction between the i -th particle and
the cell c happens at time t
(c)
i and it is assumed to be instantaneous, since its duration is
negligible with respect the macroscopic dose rate changes during the irradiation time. The
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latter assumption allows us to use the α0 and β0 parameters that describe the acute local
effect (see equation 6) due to the energy deposited by each particle track crossing the cell.190
Note that, along the irradiation process, each domain is characterized by its own specific
random sequence of interactions, in terms of specific energies and time coordinates, which
are different from any other domain. One of the benefits of performing a Monte Carlo
simulation is that it is possible to evaluate the effect of the irradiation for each domain by
considering each specific history, without evaluating averaged quantities in the computation195
of the effect on the single cell and therefore without the need to introduce correction factors,
contrarily to the original MKM formulation. Once the sequences of doses and times for each
domain of each cell have been identified via the Monte Carlo, the solution of the kinetic
equations (3) (see appendix A) allows us to evaluate the final amount of type I lethal lesions
as:200
x˜
(cd)
I =
α0
ND
nc−1∑
i=0
z
(cd)
i +
β0
ND
(
nc−1∑
i=0
z
(cd)
i
)2
− 2 β0
ND
nc−2∑
i=0
nc−1∑
j=i+1
(
1− e− 1τ (t(c)j −t(c)i )
)
z
(cd)
i z
(cd)
j (6)
where nc is a Poissonian random variable that indicates the number of particles that interact
with the cell c, with an expectation value expressed by equation 5, 1
τ
= (a + r) is the time
constant that defines the repair kinetics, α0 and β0 are the parameters of the model that
represent the acute local effect and the indexes i and j refer to the interaction of i-th and205
j-th particle respectively. Equation (6) could be recast by defining a microscopic local
Lea-Catcheside G factor [5, 7] for each cell c and domain d
Gcd = 1− 2(∑nc−1
i=0 z
(cd)
i
)2 nc−2∑
i=0
nc−1∑
j=i+1
(
1− e− 1τ (t(c)j −t(c)i )
)
z
(cd)
i z
(cd)
j (7)
that allows us to write:
x˜
(cd)
I =
α0
ND
nc−1∑
i=0
z
(cd)
i +Gcd
β0
ND
(
nc−1∑
i=0
z
(cd)
i
)2
(8)210
reproducing the LQ correlation between the total absorbed dose and the number of lethal
events. The survival probability for the single cell is evaluated by substituting the (8) in
the (4) and the computation of the final surviving fraction is made by averaging Sc over the
entire cell population:
S = 〈Sc〉c =
〈
exp
(
−
ND∑
d=1
x˜
(cd)
I
)〉
c
. (9)215
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This allows us to reproduce via the Monte Carlo a complete survival curve by varying the
imposed dose. In our simulations, values of imposed dose ranging from 1 to 6 Gy were
used. The dose absorbed by each cell fluctuates around the imposed dose due to the MC
approach, while the average dose over the cell population converges to the imposed dose.
This fluctuation is wider for higher doses due to the Poissonian statistics (equation 5). The220
corresponding LQ parameters can be obtained by fitting the simulated survival curves, as
shown in figure 1.
Figure 1. Simulated survival curves obtained for acute (light gray circles) and 30 min protracted
(dark gray triangles) monoenergetic (23.8 MeV/u) carbon ion irradiation with imposed doses rang-
ing from 1 to 6 Gy (step: 1 Gy). The dots represent the values of cell survival (a dot for each
simulated cell); the variability of the delivered dose with respect to the imposed dose derives by the
MC simulation. The two curves were fitted using the LQ model (solid and dashed lines respectively)
in order to get the LQ parameters.
An implementation of the MCt-MKM was included in a software developed by the INFN225
(Istituto Nazionale di Fisica Nucleare), which also provides the implementation of a number
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of radiobiological models and offers a useful simulation tool. The software is open source
and available on the web (https://github.com/batuff/Survival). Here, the reader interested
can find the full code used to produce the presented results.
B. Treatment planning230
The MCt-MKM was included in the treatment planning system (TPS) Rplanit (https://
github.com/planit-group/Rplanit), an extension of the original TPS PlanKIT [40] developed
by the INFN in collaboration with the IBA (Ion Beam Applications S.A.). This TPS incor-
porates a modeling approach, the beamlets superposition (BS) model, specifically conceived
to allow the simulation of beams of different ion types and complex energy spectra, includ-235
ing the nuclear fragmentation that produces a progressive build-up of secondary ions along
the penetration depth in the tissue. Track distributions have been generated using Monte
Carlo (FLUKA [41]) simulations in a water phantom irradiated with monoenergetic beams.
These distributions, collected in look-up tables, are then recombined in the patient geometry
using the BS approach and a water equivalent path length approximation. This allowed us240
to evaluate the biological effect accounting for the complete particle spectrum. We made
different treatment plans for a patient with prostate cancer applying the MCt-MKM with
the HSG parametrization (table I) and comparing the outcomes in using different primary
ions, namely H, He, Li and C. All plans are made using two lateral opposing fields, with a
total prescribed RBE weighted dose of 3 Gy(RBE) uniform in the whole planning target vol-245
ume (PTV). To show the effect of the dose rate time structure, the plans were re-evaluated
considering a protraction in the delivery of 10 minutes.
III. RESULTS
A. Acute irradiation
We validated the model through the comparison with the in vitro survival experimental250
data collected in the Particle Irradiation Data Ensamble (PIDE) by Friedrich et al. [8].
We used the data of in vitro HSG (Human Salivary Gland), V79 (Chinese hamster lung
cells) and T1 (Human lymphoblast cells) neoplastic cells exposed to acute irradiation under
aerobic conditions of H, He, C and Ne ion beams to examine the MCt-MKM calculation in
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comparison with the original MKM prediction. Figures 2, 3 and 4 show the LQ parameters255
α and β dependence on LET for the HSG, V79 and T1 cellular lines respectively comparing
experimental and simulated data.
Figure 2. Linear quadratic α (panel a) and β (panel b) parameters as a function of LET for the
irradiation of HSG cells with different ions. Points represent experimental data taken from PIDE
[8], different colors/gray levels and shapes refer to He, C and Ne ions respectively (the colour/gray
level and shape legend refers both to panel a and b). In panel a, solid and dashed lines represent
respectively the extrapolation with the MCt-MKM and the original MKM models, while in panel b
a comparison between different model is reported (namely MKM, MCt-MKM, LEM-II and RMF).
In the case of the MCt-MKM, overlapped to the α and β curves the MC statistical confidence
bands (68%) are reported. These bands are small due to the high statistics and they blends with
the curves thickness.
260
The model parameters used in the MCt-MKM calculation are summarized in table I.
These were optimized on the experimental data collected in the PIDE considering at the
same time all the ions available for the same cell line. In particular the HSG cells, used in the265
treatment planning, were optimized considering simultaneously α, β, RBE and RBE10, while
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Figure 3. Linear quadratic α (panel a) and β (panel b) parameters as a function of LET for the
irradiation of T1 cells with different ions. Points represent experimental data taken from PIDE
[8], different colors/gray levels and shapes refer to He, C and Ne ions respectively (the colour/gray
level and shape legend refers both to panel a and b). In panel a, solid and dashed lines represent
respectively the extrapolation with the MCt-MKM and the original MKM models, while in panel b
a comparison between different model is reported (namely MKM, MCt-MKM, LEM-II and RMF).
In the case of the MCt-MKM, overlapped to the α and β curves the MC statistical confidence
bands (68%) are reported. These bands are small due to the high statistics and they blends with
the curves thickness.
in the case of V79 and T1 cells we considered only the LQ parameters. Figures 2, 4 and 3 also
report a comparison between different models. In particular panel a shows the comparison
between the MKM and the MCt-MKM, evaluated with the same parameter (table I), which
predict the same behaviour for α. Panel b shows the comparison between the MKM [23],270
MCt-MKM (table I), LEM-II ([16]) and RMF [24] models, evaluated with the parameters
found in their reference paper respectively. A summary of the χ2 values obtained for each
model can be found in the supplementary materials (table S I). Such an analysis seems to
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Figure 4. Linear quadratic α (panel a) and β (panel b) parameters as a function of LET for
the irradiation of V79 cells with different ions. Points represent experimental data taken from
PIDE [8], different colors/gray levels and shapes refer to H, He, C and Ne ions respectively (the
colour/gray level and shape legend refers both to panel a and b). In panel a, solid and dashed lines
represent respectively the extrapolation with the MCt-MKM and the original MKM models, while
in panel b a comparison between different model is reported (namely MKM, MCt-MKM, LEM-II
and RMF). In the case of the MCt-MKM, overlapped to the α and β curves the MC statistical
confidence bands (68%) are reported. These bands are small due to the high statistics and they
blends with the curves thickness.
indicate a better capability of the MCt-MKM to reproduce the experimental behaviour with
respect to the other models considered.275
B. Non-acute irradiation: The G factor
We used the data of a split-dose experiment carried out by Inaniwa et al. [31] to experi-
mentally define the value of the temporal constant τ (equation 7) characteristics of the cell
repair kinetics. The experiment consists of the evaluation of the surviving fraction of HSG
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Table I. MCt-MKM parameters optimized on the experimental data from the PIDE (Particle
Irradiation Data Ensamble). For each cell line considered α0, β0, the nucleus radius Rn and the
domain radius Rd are reported.
Cell Line α0 (Gy
−1) β0 (Gy−2) Rn (µm) Rd (µm)
HSG 0.312 0.073 4.611 0.365
V79 0.104 0.045 3.748 0.364
T1 0.137 0.019 3.694 0.288
cells exposed to carbon ion irradiation (290 MeV/u) with two identical fractions of 2.5 Gy
separated by a time interval varying from 0 to 9 hours. The experimental curve (figure 5)
was interpolated using equation 7, obtaining:
τ = (23± 3) min
The band around the fitted curve in figure 5 indicates the sensibility of the survival corre-
spondent to a fluctuation of 1
τ
between ±20%.
The MCt-MKM was used to investigate the effect of the dose rate time structure in terms280
of cell survival and its effect on the radiobiological α and β parameters. Some simulations
were performed considering different ions (H, He and C) irradiating different cell populations
(HSG, T1 and V79) both in acute and non-acute conditions. For each simulation, the
difference between the radiobiological parameters identified in acute and non-acute condition
was evaluated by means of the standard normal Z -score:285
Zx =
|xAcute − xNon−Acute|√
σ2xAcute + σ
2
xNon−Acute
(10)
where x represents the parameter considered (α or β). Figure 6 shows that the dose rate
time structure modulates only the quadratic β parameter keeping unchanged the linear one,
but that the modulation decreases with increasing LET. Hence, depending on the ion and290
cell type, it could be expected that the temporal effect becomes negligible for sufficiently
high LET. This allows us to evaluate a macroscopic Lea-Catcheside G factor as:
G =
− ln 〈Sc〉c − αD
βD2
(11)
where 〈Sc〉c represents the average cell survival over the entire cell population, D the total
dose delivered while α and β represent the LQ parameters obtained in acute conditions.295
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Figure 5. Surviving fraction as a function of time between fractions in a split dose experiment.
Points represent experimental data taken from Inaniwa et al. [31], different shapes indicate different
data acquisitions. The band around the solid line corresponds to the fluctuation of 1τ between
±20%.
We found that G does not depend on LET or ion type but it is completely defined by the
dose rate time structure. Such a G factor is compatible and analytically definable as a first
order repair kinetics with the same time constant defined at the microscopic domain level
(equations 3 and 7). This is shown in figure 7 where a comparison between the simulated
G factor and its macroscopic analytical definition as a function of the fraction delivery time300
is reported in the case of protracted and fractionated irradiation respectively. In particular,
the analytical expressions used were:
G =
2
( 1
τ
T )2
(e−
1
τ
T − 1 + 1
τ
T ) (12)
in the case of protracted irradiation, where T indicates the delivery time, and
G = 1− 2
N2
N−1∑
i=1
N∑
j=i+1
(1− e− 1τ ∆tij) (13)305
in the case of fractionation, where N indicates the total number of fractions and ∆tij the
distance between the i -th and the j -th fractions.
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Figure 6. Z -score for the α and β parameters, comparing acute and non-acute irradiations for
different cell lines (HSG, T1 and V79) and different ion types (H, He and C). Points represent the
values obtained via the Monte Carlo (circles for α and triangles for β), while solid and dashed lines
are a smoothing of the data made to help the visualization of the trend for α and β respectively.
The horizontal dotted lines indicate the 95% confidence level of the normal Z -score.
C. Treatment plans
Here an exemplary case of prostate cancer is presented: figure 8 shows the distributions310
of dose-averaged LET (LETd) observed respectively for H, He, Li and C irradiations, while
figure 9 points out the resulting β spatial modulations obtained by the integration of the
MCt-MKM in the TPS. Figure 10 shows the percentage variation of the RBE expected for315
a protraction of the total delivery time of 10 minutes with respect to the acute irradiation.
Note that to define the RBE one has to clearly identify the low LET reference radiation. In
particular, for the present study, the reference radiation has be defined taking into account
explicitly the dose rate time structure. For these evaluations we choose to use as a unique
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Figure 7. Panel a) G factor as a function of the fraction delivery time, expressed in hours. Points
represent the simulated data with associated uncertainties, while the dashed line indicates the
analytical calculation (equation 12). Panel b) G factor as a function of the number of fractions, with
varying the time spacing between fractions. Points represent the simulated data with associated
uncertainties, while lines indicate the analytical calculations (equation 13); different shapes and
lines corresponds to different time spacing between fractions. The Monte Carlo data were simulated
with He at 14.22 MeV/u (both panels). The legend only refers to panel b.
reference radiation an acute (instantaneously delivered) low LET irradiation, for both acute320
ion irradiation and protracted ion irradiation. The comparison between different primary
ions indicates a higher sensitivity to the dose protraction for low-LET particles. Moreover,
in the case of H and He irradiation it was observed a localization of the effect in the target
volume where the dose is higher, while in the case of Li and C irradiation the higher β
modulations lead to a reduced sensitivity to time protraction in the target and then a325
greater effect in the entrance region.
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H He
Li C
Figure 8. Prostate cancer clinical case. Dose averaged LET distributions obtained for H, He, Li
and C beams irradiation, expressed in keV/µm.
IV. DISCUSSION
A. Radiobiological modeling
The results reported in section III A and a χ2-based analysis of different models, including330
the LEM and the original formulation of the MKM, shows a better capability of the MCt-
MKM to reproduce the experimental behaviour of both the radiobiological LQ parameters α
and β. A resuming table of the χ2 values obtained for the different models and different cell
lines is also included in the supplementary material (table S I). An interesting aspect of the
MCt-MKM model is that the Monte Carlo approach maintains the capability to reproduce335
the behaviour of different ions simultaneously, and to discriminate between them thanks
to the adoption of the ion-dependent Kiefer-Chatterjee amorphous track model following
the approach of Kase et al. [23]. The main difference with respect to the original MKM is
that the MCt-MKM predicts a non constant and vanishing β with high LET values (figures
2, 3 and 4). A saturation effect is observed for both α and β parameters. Besides our340
MC approach, this saturation effect has been introduced in 2003 in the MKM model with
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H He
Li C
Figure 9. Prostate cancer clinical case. β distributions obtained for H, He, Li and C beams
irradiation, expressed in Gy−2.
the non-Poissonian correction factor [22, 23]. An equivalent alternative correction method
is given in [29] where a saturation-corrected specific energy factor is introduced instead.
However, these LET dependent correction factors have been only evaluated explicitly for
the α parameter, while a LET independence has been assumed for the β parameter.345
The presented results shows that this non-Poissonian behaviour is automatically ac-
counted for in our MC approach without the need of auxiliary correction factors. In par-
ticular, when the LET increases, less particles are needed to deliver the same macroscopic
dose so that the radiation is densely ionizing and the damages will be highly localized. This
sparseness causes some cell not to be affected by the radiation. Moreover only few particles350
are needed to kill a cell, and if some additional particle crosses the same cell they will not be
effective with the exception of the first ones. This non-Poissonian behaviour is also respon-
sible for the decreasing β. Such a decrease is caught by the Monte Carlo approach which
accounts for the stochastic spatial correlations between different tracks while it is neglected
in the original analytical version where a constant β is assumed. Although, as previously355
noted, there are still contradictory experimental results for β vs. LET behaviour [8, 12], a
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Li C
Figure 10. Prostate cancer clinical case. Relative percentage variation of the RBE expected for a
protraction of the total delivery time of 10 minutes with respect to the acute irradiation. Values
obtained for H, He, Li and C beams irradiation.
low or negligible β parameter is to be expected for high LET particle irradiation, when a
single particle track has a high cell inactivation efficiency. This decreasing β behaviour can
be also explained in the framework of the local effect interpretation of the MKM, in which
it is the high spatially localized dose (i.e. higher specific energy deposited in few domain)360
of high LET particles that causes complex non repairable damages, thus reducing the ef-
ficacy of the repair mechanisms, that are usually associated to the parameter of the LQ
formulation. Indeed the β evaluated with LEM shows a decreasing behaviour similar the
one obtained with our MC-based MKM approach. This also highlights the analogy with the
LEM [13–18].365
The similarities between MKM and LEM have been already demonstrated in [23] where
it has been shown that the solution of the asymptotic MKM equations is compatible with
a local effect interpretation of the MKM, when an explicit track model is included in the
model. The MCt-MKM approach proposed in the present work further extends the similar-
ities between MKM and LEM, bringing a MC statistical evaluation approach to the MKM370
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evaluations similar to the one used in the original LEM formulation. In particular the MC
approach is able to reproduce correctly the non-Poissonian regime also for the β parameter,
that is neglected in the original MKM formulation, while it is accounted for in the LEM.
Interestingly, the decrease of β predicted by the MCt-MKM seems to happen at higher
LETs than the one predicted by the LEM (figures 2, 4 and 3). Nonetheless, the result is375
in contrast with the prediction of other models such as the repair-misrepair fixation (RMF)
model [24, 42] as pointed out by Carabe-Fernandez et al. [33] and, although the χ2 analysis
shows a better agreement of the MCt-MKM with the experimental data, the experimental
uncertainty related to the published data does not allow to exclude different scenarios.
As stated in section II, a further peculiarity of the MCt-MKM is that it provides the380
possibility of evaluating the temporal effect of the irradiation, intended as the variability
of the cell survival and consequently of the LQ parameters deriving from the specific dose
rate time structure considered (e.g. fractionation or protraction). Such a feature is validated
through the comparison with the experimental data, as shown in figure 5, and provides an
additional tool to compare the effect of different primary ions. This is made possible by385
the introduction of the analytic solution of the kinetic equations 3 formulated by Hawkins,
describing the temporal evolution of the DNA damages inside the cell nucleus. It was shown
(figure 6) that only the β parameter is affected by the temporal modulation and that it can be
factorized as the product of a macroscopic Lea-Catcheside G factor times the β parameter
identified in acute conditions. This is compatible with the local effect interpretation of390
the MKM introduced by Kase et al. [23]. Within this local effect interpretation, not only
the acute effect at the micrometric level of the domains is related to the macroscopic LQ
parameters of the reference low-LET radiation, but also the local repair kinetics can be
inferred from the observed macroscopic low-LET behaviour. As a consequence, the resulting
macroscopic G factor (equation 11) could be associated with the original definition in the395
case of X-ray radiation. We remark that this local effect interpretation introduces the
possibility of evaluating the temporal effect of the irradiation also in the case of the LEM,
despite of the lack of underlying kinetic equations in this model. Furthermore, in the case
of MKM, the concept of domain can be associated with the mean autocorrelation length
of the DNA damages (equation 8). This length can be experimentally measured by means400
of immunofluorescence techniques using DNA damage markers (e.g. γ-H2AX) [43]. Note
that the obtained Lea-Catcheside factor is characterized by a first order exponential repair
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kinetics as direct consequence of the formulation chosen for the kinetic equations 3.
Actually, the scientific community is divided about this subject and several authors sug-
gest the possibility of considering different repair pathways leading to multi-exponential405
repair law [44], or terms at the second order resulting in non-exponential laws such as the
hyperbolic solution introduced by Carabe-Fernandez et al. [45]. This leaves room for future
developments by introducing in the proposed model different repair kinetics formulations in
the framework of the local effect assumptions.
B. Clinical case410
As pointed out in figures 8, 9 and 10 a strong correlation occurs between the distribution
of the physical quantities (such as the dose or the LETd), the LQ radiobiological parameters
and the dose rate time structure, also depending on the chosen ion, so that the biological
effectiveness of the treatment cannot be easily predicted. By means of the MCt-MKM it
was shown that the temporal effect is mediated exclusively by the quadratic terms of the LQ415
relation (figure 6) and figures 8, 9 and 10 highlight a complex interplay between the physical
dose, the LET of the irradiation, the β parameter and the RBE. In particular, the expected
decrease of effectiveness for time protraction is stronger in the target where the dose is
higher, but it is slighter with increasing the charge of the particle used due to the lower β
resulting from the increased LET (figure 8), in agreement with the MCt-MKM predictions.420
This seems to suggest that the protons represent the best choice for a hypofractionated
treatment because of the flatten β distribution. Such an effect is minimized in the case of
carbon ions whose sensitivity to the dose rate time structure is inhibited in the high LET
region. Note that, as suggested by equations 12 and 13, the temporal effect of the irradiation
depends on the value of the repair constant τ , which has been experimentally extrapolated425
by the split-dose data (section II). These issues become relevant when thinking about a
clinical application of the model. For this purpose a sensitivity analysis of the cell survival
to this parameter has been carried out and reported in figure 5. An analysis of the impact of
τ variations to the average RBE for different protraction scenarios (from 0 to 1 hour) has also
been carried out and reported in the supplementary material (figure S5). These preliminary430
analyses show a good robustness of the model to the specific choice of the τ parameter. It
is also mandatory to emphasize that these results are intrinsically influenced by the model
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used and, even though it is compatible with the published experimental data, it is impossible
to exclude different scenarios arising from the application of other models. We remark that
the main purpose of this study was to investigate the effects of dose-delivery time structure435
on biological effectiveness in ion beam therapy. In particular, we focused on the modelling
of the repair kinetics mechanism of the cell, neglecting other time related radiobiological
mechanisms that are clinically relevant, such as the tumor repopulation dynamics. A further
limit of the modelization is that it considers cell survival as the only biological endpoint.
V. CONCLUSIONS440
A new model was presented to better reproduce the variability of the LQ parameters as
a function of the particle LET. The Monte Carlo approach to the MKM allows to account
for the stochastic nature of the irradiation process, leading to a higher precision in the esti-
mation of the quadratic β parameter which modulates the temporal effect of the irradiation.
In the case of acute irradiation, the model was validated through the comparison with the445
experimental data collected in the PIDE, while the data of a split-dose experiment were
used to experimentally define the value of the time constant characteristic of the repair
kinetics. The model has been included in the TPS and used to analyse a case of prostate
cancer irradiated with different primary ions with a protracted dose delivery. A complex
interconnection was found between the physical and radiobiological quantities, which cer-450
tainly needs further and more detailed studies. In this context, the MCt-MKM provides a
new tool to optimize treatment plans with a better control of the radiobiological quantities
and to evaluate the effect of using different sources and advanced delivery techniques with
complex dose rate time structures, such as repainting or respiratory gating.
Appendix A: Solution of the kinetic equations455
The solution of the kinetic equations (3) represents one of the key points of the MCt-
MKM. This appendix is intended to drive the reader in the solution of these equations,
clarifying the passages that leads from equation 3 to equation 6.
Consider a cell from a population exposed to irradiation at the time t = 0 and a domain
absorbing z in the interaction with an ion. Then, according to equation 3, it is possible to460
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define the boundary conditions: x
(cd)
I (t = 0) = λ z
(cd)
x
(cd)
II (t = 0) = k z
(cd)
(A1)
The indexes c and d refers to the cell and the domain: from now they will be omitted to
make the equation more readable. In this case the solution of the kinetic equation for xII is
a simple exponential, which imply:465 
xI(t) = λz +
∫ t
0
[
a kz e−(a+r)t
′
+ b k2z2 e−2(a+r)t
′
]
dt′
xII(t) = kz e
−(a+r)t
(A2)
where the integral defining xI can be easily solved, resulting (in the limit of t→∞) in:
xI =
(
λ+
ak
a+ r
)
z +
(
bk2
2(a+ r)
)
z2 (A3)
which highlights the linear and quadratic components of the lethal damages. This process
needs to be generalized to consider a sequence of n consecutive interactions occurring at the470
times {t0, t1, . . . , tn−1}, in which the domain absorbs {z0, z1, . . . , zn−1}. The solution of
equation 3 for xII , in this case, has to be split in n time intervals:
xII(t) =

kz0 exp [−(a+ r)(t− t0)] ≡ x(0)II t0 < t < t1
kz0 exp [−(a+ r)(t− t0)) + kz1 exp (−(a+ r)(t− t1)] ≡ x(1)II t1 < t < t2
...
...
n−2∑
i=0
kzi exp [−(a+ r)(t− ti)] ≡ x(n−2)II tn−2 < t < tn−1
n−1∑
i=0
kzi exp [−(a+ r)(t− ti)] ≡ x(n−1)II t > tn−1
(A4)
The integral defining xI (equation A2) has to be split as well in n integrals:
xI(t) =
n−2∑
i=0
[
λzi +
∫ ti+1
ti
(
ax
(i)
II + bx
(i)
II
2
)
dt
]
+ λzn−1 +
∫ t
tn−1
(
ax
(n−1)
II + bx
(n−1)
II
2
)
dt′ (A5)475
which can be solved in the same way of A2, in the limit of t→∞, leading to:
xI =
α0
ND
n−1∑
i=0
zi +
β0
ND
n−1∑
i=0
z2i +
β0
ND
n−2∑
i=0
n−1∑
j=i+1
e−(a+r)(tj−ti)2zizj (A6)
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being: 
α0
ND
= λ+
ak
a+ r
β0
ND
=
bk2
2(a+ r)
. (A7)
Equation 6 can be obtained by subtracting and adding to equation A6 the quantity:480
β0
ND
n−2∑
i=0
n−1∑
j=i+1
2zizj . (A8)
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